TerraPlant
Through a proprietary process, we can produce small molecules and proteins.
The focus of our first initiative will be rare cannabinoids and terpenes to establish ourselves in the $100 billion emerging market.
Our process can also be used to produce vaccines, insulin, vitamins, biofuels, opioids and protein supplements.